Back to Search Start Over

ESPEN guidelines on chronic intestinal failure in adults.

Authors :
Pironi, Loris
Arends, Jann
Bozzetti, Federico
Cuerda, Cristina
Gillanders, Lyn
Jeppesen, Palle Bekker
Joly, Francisca
Kelly, Darlene
Lal, Simon
Staun, Michael
Szczepanek, Kinga
Van Gossum, André
Wanten, Geert
Schneider, Stéphane Michel
Source :
Clinical Nutrition; Apr2016, Vol. 35 Issue 2, p247-307, 61p
Publication Year :
2016

Abstract

Summary Background & aims Chronic Intestinal Failure (CIF) is the long-lasting reduction of gut function, below the minimum necessary for the absorption of macronutrients and/or water and electrolytes, such that intravenous supplementation is required to maintain health and/or growth. CIF is the rarest organ failure. Home parenteral nutrition (HPN) is the primary treatment for CIF. No guidelines (GLs) have been developed that address the global management of CIF. These GLs have been devised to generate comprehensive recommendations for safe and effective management of adult patients with CIF. Methods The GLs were developed by the Home Artificial Nutrition & Chronic Intestinal Failure Special Interest Group of ESPEN. The GRADE system was used for assigning strength of evidence. Recommendations were discussed, submitted to Delphi rounds, and accepted in an online survey of ESPEN members. Results The following topics were addressed: management of HPN; parenteral nutrition formulation; intestinal rehabilitation, medical therapies, and non-transplant surgery, for short bowel syndrome, chronic intestinal pseudo-obstruction, and radiation enteritis; intestinal transplantation; prevention/treatment of CVC-related infection, CVC-related occlusion/thrombosis; intestinal failure-associated liver disease, gallbladder sludge and stones, renal failure and metabolic bone disease. Literature search provided 623 full papers. Only 12% were controlled studies or meta-analyses. A total of 112 recommendations are given: grade of evidence, very low for 51%, low for 39%, moderate for 8%, and high for 2%; strength of recommendation: strong for 63%, weak for 37%. Conclusions CIF management requires complex technologies, multidisciplinary and multiprofessional activity, and expertise to care for both the underlying gastrointestinal disease and to provide HPN support. The rarity of the condition impairs the development of RCTs. As a consequence, most of the recommendations have a low or very low grade of evidence. However, two-thirds of the recommendations are considered strong. Specialized management and organization underpin these recommendations. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
02615614
Volume :
35
Issue :
2
Database :
Supplemental Index
Journal :
Clinical Nutrition
Publication Type :
Academic Journal
Accession number :
113826510
Full Text :
https://doi.org/10.1016/j.clnu.2016.01.020